TY  - EJOU
AU  - Garcia, Jorge E. 
AU  - Thiel, David D. 
AU  - Broderick, Gregory A. 

TI  - BCG pyelonephritis following intravesical therapy for transitional cell carcinoma
T2  - Canadian Journal of Urology

PY  - 2007
VL  - 14
IS  - 2
SN  - 1488-5581

AB  - Bacillus Calmette-Guerin (BCG) is a common
intravesical agent utilized for superficial transitional cell
carcinoma of the bladder. The potential for side effects
and complications does exist secondary to the utilization
of live attenuated bacteria. We present the case of a 70-
year old male that developed BCG pyelonephritis and
associated renal mass following the fifth of six weekly
intravesical BCG therapies. The patient improved
clinically and renal mass resolved following 3 months of
isoniazid monotherapy without renal biopsy.
KW  - bladder neoplasm
KW  -  BCG
KW  -  intravesical therapy

DO  -